Interleukin-2 in CD8+T cells correlates with Banff score during organ rejection in liver transplant recipients

被引:29
作者
Akoglu, Bora [1 ]
Kriener, Susanne [3 ]
Martens, Swantje [2 ]
Herrmann, Eva [2 ]
Hofmann, Wolf Peter [2 ]
Milovic, Vladan [4 ]
Zeuzem, Stefan [2 ]
Faust, Dominik [1 ]
机构
[1] Asklepios Med Ctr, Dept Internal Med 2, D-63225 Langen, Germany
[2] Klinikum Johann Wolfgang Goethe Univ, Dept Internal Med 1, D-60590 Frankfurt, Germany
[3] Klinikum Johann Wolfgang Goethe Univ, Senckenberg Inst Pathol, D-60590 Frankfurt, Germany
[4] MediClin Deister Weser Kliniken, D-31848 Bad Muender, Germany
关键词
Liver transplantation; Rejection; Interleukin-2; Flow cytometry; Banff score; ALLOGRAFT-REJECTION; 2-DOSE REGIMEN; CYCLOSPORINE-A; CALCINEURIN; DACLIZUMAB; MECHANISM; THERAPY;
D O I
10.1007/s10238-009-0042-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of this study is to compare the histological grading of acute organ rejection according to the Banff score with intracellular interleukin-2 (IL-2) concentrations in cytotoxic CD8+ T cells from peripheral blood samples. 66 recipients after liver transplantation and 20 healthy controls were included into this study. Blood samples of liver transplant recipients were collected beside routine visits or, in case of suspected organ rejection, with additional liver biopsy. For cytometry, the blood cells were stained with CD3, CD8 and intracellular-IL-2. The percentage of cells with detectable intracellular IL-2 was significantly increased in patients with acute rejection (n = 7, P < 0.001, t Test) compared to recipients without rejection. The percentage of cells with detectable intracellular IL-2 (mean +/- A SEM) was 7.6 +/- A 0.9% in rejection patients, 2.3 +/- A 0.22% in stable liver transplant recipients, and 14 +/- A 2.99% in healthy controls. Intracellular IL-2 correlates to the Banff score in rejection patients (Spearmans-rho = 0.81, P < 0.05). This cytometric method shows a good sensitivity (71%) with a cut-off based on a high specificity of 95% for histological proven organ rejection in our study cohort. Measurement of intracellular IL-2 in cytotoxic CD8+ T-lymphocytes by flow cytometry correlates very well to the histological grading according to the Banff score and shows a good sensitivity and excellent specificity in acute organ rejection.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 18 条
[1]   Acute cellular rejection in liver transplant recipients under cyclosporine immunosuppression:: Predictive factors of response to antirejection therapy [J].
Andreu, H ;
Rimola, A ;
Bruguera, M ;
Navara, M ;
Cirera, I ;
Grande, L ;
García-Valdecasas, JC ;
Rodés, J .
TRANSPLANTATION, 2002, 73 (12) :1936-1943
[2]   CALCINEURIN ACTIVITY IS ONLY PARTIALLY INHIBITED IN LEUKOCYTES OF CYCLOSPORINE-TREATED PATIENTS [J].
BATIUK, TD ;
PAZDERKA, F ;
HALLORAN, PF .
TRANSPLANTATION, 1995, 59 (10) :1400-1404
[3]   Defective inhibition of peripheral CD8+T cell IL-2 production by anti-calcineurin drugs during acute liver allograft rejection [J].
Boleslawski, E ;
Conti, F ;
Sanquer, S ;
Podevin, P ;
Chouzenoux, S ;
Batteux, F ;
Houssin, D ;
Weill, B ;
Calmus, Y .
TRANSPLANTATION, 2004, 77 (12) :1815-1820
[4]   ENHANCED RISK OF STEROID-RESISTANT ACUTE REJECTION FOLLOWING PRETRANSPLANT STEROID-THERAPY IN LIVER GRAFT RECIPIENTS [J].
CONTI, F ;
DOUSSET, B ;
ARCHAMBEAU, D ;
LOUVEL, A ;
HOUSSIN, D ;
CALMUS, Y .
TRANSPLANTATION, 1995, 60 (10) :1104-1108
[5]   PERIPHERAL TOLERANCE TO ALLOANTIGEN RESULTS FROM ALTERED REGULATION OF THE INTERLEUKIN-2 PATHWAY [J].
DALLMAN, MJ ;
SHIHO, O ;
PAGE, TH ;
WOOD, KJ ;
MORRIS, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (01) :79-87
[6]   Experience with daclizumab in liver transplantation - Renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation [J].
Hirose, R ;
Roberts, JP ;
Quan, D ;
Osorio, RW ;
Freise, C ;
Ascher, NL ;
Stock, PG .
TRANSPLANTATION, 2000, 69 (02) :307-311
[7]   The mechanism of action of cyclosporin A and FK506 [J].
Ho, S ;
Clipstone, N ;
Timmermann, L ;
Northrop, J ;
Graef, I ;
Fiorentino, D ;
Nourse, J ;
Crabtree, GR .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1996, 80 (03) :S40-S45
[8]   Cyclosporine induces cancer progression by a cell-autonomous mechanism [J].
Hojo, M ;
Morimoto, T ;
Maluccio, M ;
Asano, T ;
Morimoto, K ;
Lagman, M ;
Shimbo, T ;
Suthanthiran, M .
NATURE, 1999, 397 (6719) :530-534
[9]   Pharmacokinetics, pharmacodynamics, and immunodynamics of daclizumab in a two-dose regimen in liver transplantation [J].
Koch, M ;
Niemeyer, G ;
Patel, I ;
Light, S ;
Nashan, B .
TRANSPLANTATION, 2002, 73 (10) :1640-1646
[10]   CALCINEURIN IS A COMMON TARGET OF CYCLOPHILIN-CYCLOSPORINE-A AND FKBP-FK506 COMPLEXES [J].
LIU, J ;
FARMER, JD ;
LANE, WS ;
FRIEDMAN, J ;
WEISSMAN, I ;
SCHREIBER, SL .
CELL, 1991, 66 (04) :807-815